The Stanford Ophthalmology 2021 Annual Report, "Vision Matters: The Eye-Brain Connection" highlights the department's recent news and accomplishments. Click here to read or download the PDF.

Want to view previous issues? Click the images below!

In this Issue

For image credits, view PDF

  • A note from our Chair

    2021 marked a hopeful new chapter and my sixth year back at Stanford.

  • An eye-brain connection: Groundbreaking advancements for neurorehabilitation patients

    Our vision depends not just on our eyes, but on the full visual pathway from eye to brain.

  • Shedding light on rare diseases

    Yang Sun, MD, PhD, associate professor of ophthalmology, is a clinician-scientist who has devoted the past decade to searching for a cure for a rare disease known as Lowe syndrome.

  • Saving vision with gene therapies

    Vinit Mahajan, MD, PhD, associate professor of ophthalmology and vice-chair for research, is leading two human gene therapy trials, one for dry age-related macular degeneration (AMD) and a second for an inherited form of retinal disease caused by the retinitis pigmentosa GTPase regulator gene.

  • Biorepository: A new key to precision health

    The lack of laboratory models for human eye diseases is a roadblock to translational research, but it drove Vinit Mahajan, MD, PhD, associate professor of ophthalmology and vice chair for research, to forge a scientific path that promises to lead to medical discoveries.

  • Eyecare at all ages: Bringing vision restoration to pediatric patients

    The Byers Eye Institute at Stanford provides care to patients of all ages, including our pediatric patients from birth to 21 years old, under the auspices of the Lucile Packard Children’s Hospital Stanford (LPCH), with three state-of-the-art facilities.

  • New center tackles rapidly growing myopia prevalence

    The prevalence of myopia, or nearsightedness, continues to grow, affecting about 42% of the entire American population.